Other languages Accuray Incorporated

Equities

ARAY

US0043971052

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-14 pm EDT			5-day change	1st Jan Change
1.6 ^USD	+1.27%		-8.57%	-43.46%

May. 10	Accuray Incorporated Announces Executive Changes, Effective May 17, 2024	CI
May. 01	Earnings Flash (ARAY) ACCURAY INCORPORATED Posts Q3 Revenue $101.1M, vs. Street Est of $113.6M	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Accuray Incorporated Announces Executive Changes, Effective May 17, 2024	May. 10
Accuray Incorporated Provides Earnings Guidance for the Year 2024	May. 01
Accuray Incorporated Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	May. 01
Accuray Incorporated Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024	Apr. 25
Accuray Incorporated Expands Global Training Center Network with Opening of New Facility in Genolier, Switzerland	Apr. 18
Accuray Incorporated Announces New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can Be Effectively Treated in 5 Days Using the Accuray CyberKnife System	Mar. 26
Quebec Cancer Center Is First in Canada to Treat Cancer Patients Using the Accuray Radixact System	Feb. 13
Accuray Incorporated Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Jan. 31
Accuray Incorporated Reaffirms Revenue Guidance for the Third Quarter and Full Fiscal Year 2024	Jan. 31
Accuray Incorporated Announces the Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray Cyberknife System	Jan. 25
Accuray Insider Sold Shares Worth $161,624, According to a Recent SEC Filing	Dec. 05
Accuray Incorporated Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 07
Accuray Shares Rise After Securing Approval for Tomo C Radiation Therapy System in China	23-10-04
Accuray Secures Approval for Tomo C Radiation Therapy System in China	23-10-03
Accuray Announces Approval of the Tomo C Radiation Treatment Delivery System by China's National Medical Products Administration	23-10-03
Accuray Partners With Limbus AI to Launch Online Adaptive Therapy for Radixact System	23-10-02
Accuray Incorporated and Limbus AI Unveil Online Adaptive Therapy Solution for Radixact System at American Society for Radiation Oncology Annual Meeting	23-10-02
Accuray Incorporated Opens the Doors of its New Global Training Facility, the Accuray Center for Education, Located At its Corporate Headquarters in Madison, Wisconsin	23-09-18
Accuray Gets US FDA Clearance for Addition of New Functionality to Radixact System for Breast Cancer Treatment	23-08-10
Accuray Incorporated Receives FDA Clearance for VitalHold on the Radixact System; Breast Cancer Treatment Option Will Also Be Available in the EU Market	23-08-09

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Accuray Incorporated

Equities

ARAY

US0043971052

Other languages

Filters